Lactobacillus reuteri ADR-1

Lactobacillus reuteri ADR-1 is a specific, patented strain of one of the most naturally occurring beneficial bacteria in the human gut. L. reuteri has been a resident of the human digestive tract for thousands of years, and the ADR-1 strain was carefully selected from a library of candidates for its standout ability to influence blood sugar regulation. Think of your gut microbiome like a diverse neighborhood — when the right residents are present in good numbers, the whole community runs more smoothly. ADR-1 acts like a highly effective neighborhood captain: it not only keeps order in the gut itself but also sends signals that help your liver and cells respond better to insulin, the hormone that controls how your body manages glucose.

The most exciting benefit of L. reuteri ADR-1 is its support for blood sugar management in people living with type 2 diabetes. In clinical studies, people who took this strain daily experienced a noticeable drop in HbA1c — the key marker doctors use to track long-term blood sugar control — compared to those on a placebo. But that's not all: participants also saw improvements in their cholesterol levels, which is hugely important because high blood sugar and high cholesterol often travel together, raising the risk of heart complications. Beyond blood sugar, ADR-1 has been shown to positively reshape the gut microbiome itself. After supplementation, levels of beneficial bacteria in the gut increased, creating a healthier internal environment that may amplify the metabolic benefits over time. The results were most striking in people whose gut L. reuteri levels increased the most — suggesting that actually colonizing the gut is key to getting the full benefit.

L. reuteri ADR-1 has a strong safety profile and is generally very well tolerated. It is suitable for most adults looking to support their metabolic health as part of a broader healthy lifestyle, including those already managing type 2 diabetes alongside conventional treatment. It's typically taken as a daily live-culture supplement for a minimum of three months to allow adequate time for the gut microbiome to shift and for metabolic markers to respond. Common forms include capsules and powder sachets that can be mixed with water or a cool beverage. As a secondary benefit, ADR-1 supplementation has been associated with reduced levels of an inflammatory marker called IL-1β — a molecule involved in low-grade inflammation that is often elevated in metabolic conditions. As always, anyone with diabetes or a serious metabolic condition should consult their healthcare provider before adding any new supplement to their routine.